A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen

被引:196
作者
Barascuk, N. [1 ,3 ]
Veidal, S. S. [1 ,4 ]
Larsen, L. [1 ]
Larsen, D. V. [1 ]
Larsen, M. R. [5 ]
Wang, J. [2 ]
Zheng, Q. [2 ]
Xing, R. [2 ]
Cao, Y. [2 ]
Rasmussen, L. M. [3 ]
Karsdal, M. A. [1 ,3 ]
机构
[1] Nord Biosci AS, Herlev, Denmark
[2] Nord Biosci Beijing, Beijing, Peoples R China
[3] Univ So Denmark, Dept Biochem Pharmacol & Genet, Odense Univ Hosp, Odense M, Denmark
[4] Univ So Denmark, Inst Clin, Odense M, Denmark
[5] Univ So Denmark, Inst Biochem & Mol Biol, Odense M, Denmark
关键词
Extracellular matrix remodelling; Type III collagen; Matrix-metallo-proteinase-9; Liver fibrosis; ELISA; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; THERAPEUTIC TARGETS; MOUSE MODELS; BIOMARKERS; OSTEOARTHRITIS; METALLOPROTEINASES; CELLS; BONE;
D O I
10.1016/j.clinbiochem.2010.03.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Objectives: Accumulation of extracellular matrix (ECM) components and increased matrix-metalloprotease (MMPs) activity are hallmarks of fibrosis. We developed an ELISA for quantification of MMP-9 derived collagen type III (CO3) degradation. Design and methods: A monoclonal antibody targeting a specific MMP-9 cleaved fragment of CO3 was used for development of a competitive ELISA. The assay was investigated in serum and tissues from bile duct ligated rats (BDL). Results: The ELISA showed no cross-reaction with either intact CO3, or other collagens. The intra- and inter-assay CV were below 10%. Liver fibrosis was demonstrated in BDL animals by semi quantitative scoring (P<0.0001). Serum levels of CO3-610 increased 2.5 fold in BDL animals (P<0.001). The CO3-610 levels were 5 fold higher in ex vivo cultures of fibrotic livers compared to controls (P<0.001). Conclusion: We have developed a novel ELISA for measuring a specific fragment CO3 generated by MMP-9 important in pathogenesis of liver fibrosis. (c) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:899 / 904
页数:6
相关论文
共 29 条
[1]
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women:: A new potential treatment of osteoarthritis [J].
Bagger, YZ ;
Tankó, LB ;
Alexandersen, P ;
Karsdal, MA ;
Olson, M ;
Mindeholm, L ;
Azria, M ;
Christiansen, C .
BONE, 2005, 37 (03) :425-430
[2]
Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[3]
Classification of osteoarthritis biomarkers:: a proposed approach [J].
Bauer, D. C. ;
Hunter, D. J. ;
Abramson, S. B. ;
Attur, M. ;
Corr, M. ;
Felson, D. ;
Heinegard, D. ;
Jordan, J. M. ;
Kepler, T. B. ;
Lane, N. E. ;
Saxne, T. ;
Tyree, B. ;
Kraus, V. B. .
OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) :723-727
[4]
BOTNEY MD, 1992, AM J PATHOL, V140, P357
[5]
Reducing risks to health, promoting healthy life [J].
Brundtland, GH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :1974-1974
[6]
Liver fibrosis - from bench to bedside [J].
Friedman, SL .
JOURNAL OF HEPATOLOGY, 2003, 38 :S38-S53
[7]
Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly [J].
Galis, ZS ;
Khatri, JJ .
CIRCULATION RESEARCH, 2002, 90 (03) :251-262
[8]
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation [J].
Garnero, P ;
Ferreras, M ;
Karsdal, MA ;
Nicamhlaoibh, R ;
Risteli, J ;
Borel, O ;
Qvist, P ;
Delmas, PD ;
Foged, NT ;
Delaissé, JM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) :859-867
[9]
SIMPLE METHOD FOR POLYETHYLENE GLYCOL-PROMOTED HYBRIDIZATION OF MOUSE MYELOMA CELLS [J].
GEFTER, ML ;
MARGULIES, DH ;
SCHARFF, MD .
SOMATIC CELL GENETICS, 1977, 3 (02) :231-236
[10]
Collagens -: structure, function, and biosynthesis [J].
Gelse, K ;
Pöschl, E ;
Aigner, T .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (12) :1531-1546